VCRE NASDAQ
Vicore Pharma Holding AB
1W: -3.3%
1M: -17.0%
3M: -42.6%
YTD: -42.6%
$9.33
-0.10 (-1.06%)
Weekly Expected Move ±5.4%
$8
$9
$9
$10
$10
Overview
Chart
Smart Money
Financials
Income Statement
Cash Flow
Balance Sheet
Earnings
Analysis
Technicals
Weather
Peers
ESG
Institutions
Dark Pool
Short Interest
Smart Money Score
No convergence signal
Key Statistics
Market Cap$2.6B
52W Range8.79-17.8
Volume27,502
Avg Volume27,642
Beta0.15
Dividend—
Analyst Ratings
No analyst coverage
Company Info
CEOAhmed Mousa
Employees37
SectorHealthcare
IndustryBiotechnology
IPO Date2026-07-02
Websitevicorepharma.com
Kornhamnstorg 53
Stockholm, AB 111 27
SE
Stockholm, AB 111 27
SE
About Vicore Pharma Holding AB
Vicore Pharma Holding AB is a pharmaceutical company, which engages in the development of drugs with focus on interstitial lung diseases and related indications. Its drug development programs include VP01, VP02, VP03, and VP04. The company was founded in 2000 sand is headquartered in Stockholm, Sweden.
Recent Insider Trades
No insider trades found